Thermo Fisher Scientific Inc. (TMO) 주식 — 좋은 사업일까?

Thermo Fisher Scientific Inc. (TMO) 주식 — 좋은 사업일까? — InspectStocks

어떻게 돈을 버는가

Laboratory Products and Biopharma Services53%
Life Sciences Solutions20%
Analytical Instruments17%
Specialty Diagnostics10%

매출 비중은 year ended December 31, 2025 기준 추정치이며, 제출된 보고서의 수치가 아닙니다.

경쟁 상대

무엇을 파는가6

Thermo Scientific Orbitrap Tribrid Apex Mass Spectrometer
An instrument that measures molecules in samples to help researchers study complex biology, medicines, and other substances.
Thermo Scientific Vanquish Amplify ultra-high-performance liquid chromatography system
An instrument that separates and analyzes substances in liquid samples, including sensitive biological molecules.
Applied Biosystems PowerFlex Thermal Cycler
A laboratory instrument that repeatedly heats and cools samples to copy selected genetic material for testing or research.

3개 더 보기

DynaDrive single-use bioreactors
Containers and equipment used to grow cells and produce medicines; the single-use parts are replaced between production runs.
Diagnostic test kits and reagents
Tests and the chemicals needed to detect or monitor conditions such as allergies, thyroid disorders, infections, and drug levels.
PPD and Patheon services
PPD provides clinical research and clinical-trial services; Patheon develops and manufactures medicines for pharmaceutical and biotechnology customers.

누가 사는가5

Pharmaceutical and biotechnology companies buy research supplies, instruments, drug-development and clinical-trial services, and equipment and materials for medicine production, through direct sales and purchasing channels.
Hospitals, clinical laboratories, and physicians’ offices buy diagnostic tests, reagents, instruments, and laboratory supplies.
Universities, research institutions, and government agencies buy research products and scientific instruments, often using grant or government funding.

2개 더 보기

Industrial and applied-science customers buy instruments and testing products for areas such as environmental testing, safety, manufacturing, and quality control.
Food-safety and other testing laboratories buy diagnostic kits, reagents, culture media, and related instruments.

무엇에 기대고 있고, 무엇이 무너뜨릴 수 있는가

사업이 기대고 있는 것

1Demand depends in part on pharmaceutical and biotechnology customer spending, research budgets, government funding, and customers’ plans for buying laboratory equipment.
2Some materials or components come from a single supplier or a limited number of suppliers, and the company also relies heavily on third-party package-delivery services to ship products.
3The company relies on scientific, technical, clinical, and management employees and on complying with regulations that apply to laboratory products, diagnostics, medicine services, data, and government contracts.
4Its clinical research and medicine-manufacturing services depend on delivering complex work to customers on time and to required quality standards.

잘못될 수 있는 일

1Revenue can be affected when pharmaceutical, biotechnology, academic, government, or industrial customers reduce spending, delay equipment purchases, or face changes in research funding.
2The company must keep developing products and responding to technological changes and competing products while maintaining product quality; failure to do so could reduce demand.
3Its complex clinical research and medicine-manufacturing work can be affected by delays or quality problems, while a cyberattack or breach of information systems could disrupt operations or expose protected data.

전체 재무제표 보기 →

Thermo Fisher Scientific Inc. 소개

Thermo Fisher sells products and services to pharmaceutical and biotechnology companies, hospitals, clinical laboratories, universities, government agencies, and industrial customers. Its products include research supplies, instruments for analyzing samples, and diagnostic tests; its services include clinical-trial work and manufacturing medicines for customers. In the second quarter of 2026, management said customer demand had strengthened across its major markets.

본사: Waltham, Massachusetts, United States
설립: 2006
임직원 수: Approximately 125,000 (December 31, 2025, high)
상장 시장: New York Stock Exchange
회계연도 종료: December 31

Thermo Fisher Scientific Inc.이(가) 미국 증권거래위원회(SEC)에 직접 제출한 공시로 만들었습니다. 수치는 보고된 그대로이며, 주당 이력은 오늘의 주식 수 기준으로 재계산했습니다. 이것은 사업을 설명하는 자료입니다. 투자 자문이 아니며 어떤 매수나 매도도 권유하지 않습니다.

Keep exploring

The themes Thermo Fisher Scientific is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.

The themes it is part of

Highest-graded in Diagnostics and Research

Graded A or B and worth $2B or more: A first, then the largest.

Grade rose recently in Healthcare

Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.

어떻게 돈을 버는가

Laboratory Products and Biopharma Services53%
Life Sciences Solutions20%
Analytical Instruments17%
Specialty Diagnostics10%

매출 비중은 year ended December 31, 2025 기준 추정치이며, 제출된 보고서의 수치가 아닙니다.

경쟁 상대

무엇을 파는가6

Thermo Scientific Orbitrap Tribrid Apex Mass Spectrometer
An instrument that measures molecules in samples to help researchers study complex biology, medicines, and other substances.
Thermo Scientific Vanquish Amplify ultra-high-performance liquid chromatography system
An instrument that separates and analyzes substances in liquid samples, including sensitive biological molecules.
Applied Biosystems PowerFlex Thermal Cycler
A laboratory instrument that repeatedly heats and cools samples to copy selected genetic material for testing or research.

3개 더 보기

DynaDrive single-use bioreactors
Containers and equipment used to grow cells and produce medicines; the single-use parts are replaced between production runs.
Diagnostic test kits and reagents
Tests and the chemicals needed to detect or monitor conditions such as allergies, thyroid disorders, infections, and drug levels.
PPD and Patheon services
PPD provides clinical research and clinical-trial services; Patheon develops and manufactures medicines for pharmaceutical and biotechnology customers.

누가 사는가5

Pharmaceutical and biotechnology companies buy research supplies, instruments, drug-development and clinical-trial services, and equipment and materials for medicine production, through direct sales and purchasing channels.
Hospitals, clinical laboratories, and physicians’ offices buy diagnostic tests, reagents, instruments, and laboratory supplies.
Universities, research institutions, and government agencies buy research products and scientific instruments, often using grant or government funding.

2개 더 보기

Industrial and applied-science customers buy instruments and testing products for areas such as environmental testing, safety, manufacturing, and quality control.
Food-safety and other testing laboratories buy diagnostic kits, reagents, culture media, and related instruments.

무엇에 기대고 있고, 무엇이 무너뜨릴 수 있는가

사업이 기대고 있는 것

1Demand depends in part on pharmaceutical and biotechnology customer spending, research budgets, government funding, and customers’ plans for buying laboratory equipment.
2Some materials or components come from a single supplier or a limited number of suppliers, and the company also relies heavily on third-party package-delivery services to ship products.
3The company relies on scientific, technical, clinical, and management employees and on complying with regulations that apply to laboratory products, diagnostics, medicine services, data, and government contracts.
4Its clinical research and medicine-manufacturing services depend on delivering complex work to customers on time and to required quality standards.

잘못될 수 있는 일

1Revenue can be affected when pharmaceutical, biotechnology, academic, government, or industrial customers reduce spending, delay equipment purchases, or face changes in research funding.
2The company must keep developing products and responding to technological changes and competing products while maintaining product quality; failure to do so could reduce demand.
3Its complex clinical research and medicine-manufacturing work can be affected by delays or quality problems, while a cyberattack or breach of information systems could disrupt operations or expose protected data.

전체 재무제표 보기 →

Thermo Fisher Scientific Inc. 소개

본사: Waltham, Massachusetts, United States
설립: 2006
임직원 수: Approximately 125,000 (December 31, 2025, high)
상장 시장: New York Stock Exchange
회계연도 종료: December 31

어떻게 돈을 버는가

경쟁 상대

무엇을 파는가6

누가 사는가5

무엇에 기대고 있고, 무엇이 무너뜨릴 수 있는가

사업이 기대고 있는 것

잘못될 수 있는 일

Thermo Fisher Scientific Inc. 소개

Keep exploring

The themes it is part of

Highest-graded in Diagnostics and Research

Grade rose recently in Healthcare

어떻게 돈을 버는가

경쟁 상대

무엇을 파는가6

누가 사는가5

무엇에 기대고 있고, 무엇이 무너뜨릴 수 있는가

사업이 기대고 있는 것

잘못될 수 있는 일

Thermo Fisher Scientific Inc. 소개

Keep exploring

The themes it is part of

Highest-graded in Diagnostics and Research

Grade rose recently in Healthcare

Lab tools & diagnostics

Thermo Fisher Scientific Inc.

성장과 현금 — 5개 중 5개

사업 추세

주가와 등급 추이

어떻게 돈을 버는가

경쟁 상대

무엇을 파는가6

누가 사는가5

무엇에 기대고 있고, 무엇이 무너뜨릴 수 있는가

사업이 기대고 있는 것

잘못될 수 있는 일

Thermo Fisher Scientific Inc. 소개

Keep exploring

The themes it is part of

Highest-graded in Diagnostics and Research

Grade rose recently in Healthcare

어떻게 돈을 버는가

경쟁 상대

무엇을 파는가6

누가 사는가5

무엇에 기대고 있고, 무엇이 무너뜨릴 수 있는가

사업이 기대고 있는 것

잘못될 수 있는 일

Thermo Fisher Scientific Inc. 소개

Keep exploring

The themes it is part of

Highest-graded in Diagnostics and Research

Grade rose recently in Healthcare

Lab tools & diagnostics

Thermo Fisher Scientific Inc.

과거 수익률

성장과 현금 — 5개 중 5개

사업 추세

주가와 등급 추이